Coordinated elevation of membrane type 1-matrix metalloproteinase and matrix metalloproteinase-2 expression in rat uterus during postpartum involution

Reproductive Biology and Endocrinology

Volumn 4, Issue , 2006, Pages

  Manase, Kengo ^a   Endo, Toshiaki ^a   Chida, Mitunobu ^a   Nagasawa, Kunihiko ^a   Honnma, Hiroyuki ^a   Yamazaki, Kiyohiro ^a   Kitajima, Yoshimitu ^a   Goto, Taeko ^a   Kanaya, Mika ^a   Hayashi, Takuhiro ^a   Mitaka, Toshihiro ^b   Saito, Tsuyoshi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Mica Ladies Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; FEMALE; IMMUNOHISTOCHEMISTRY; INVOLUTION; LEYDIG CELL; NONHUMAN; NORTHERN BLOTTING; PREGNANCY; PROTEIN EXPRESSION; PUERPERIUM; RAT; TIME; TISSUE REGENERATION; UTERUS; ZYMOGRAPHY;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; POSTPARTUM PERIOD; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; UTERUS;

RODENTIA;

EID: 33747165047     PISSN: 14777827     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-4-32     Document Type: Article

References (39)

1. Woessner JF Jr: Matrix metalloproteinase and their inhibitors in connective tissue remodeling. FASEB J 1991, 5(8):2145-2154.
2. Matrisian LM: The matrix-degrading metalloproteinases. Bioessays 1992, 14(7):455-463.
3. Oikarinen A, Kylmefniemi M, Autio-Harmainen H, Autio P, Salo T: Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. J Invest Dermatol 1992, 101(2):205-210.
4. Saarialho-Kere UK, Kovacs SO, Pentland AP, Olerud JE, Welgus HG, Parks WC: Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest 1993, 92(3):2858-2866.
5. Shimonnvitz S, Hurwitz A, Dushnik M, Anteby E, Geva-Eldar T, Yagel S: Developmental regulation of the expression of 72 and 92 kd type IV collagenase in human trophoblast: a possible mechanism for control of trophoblast invasion. Am J Obstet Gynecol 1994, 171(3):832-838.
6. Lala PK, Graham CH: Mechanisms of trophoblast invasiveness and their control: the role of protease inhibitors. Cancer Metastasis Rev 1991, 9(4):369-379.
7. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z: Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinase in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 1994, 125(3):681-693.
8. Witty JP, Wright J, Matrisian LM: Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol Biol Cell 1995, 6(10):1287-1303.
9. Woessner JF Jr, Taplin C: Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem 1988, 263(3):16918-16925.
10. Sellers A, Woessner JF Jr: The extraction of a neutral metalloproteinase from the involuting rat uterus, and its action on cartilage proteoglycan. Biochem J 1980, 189(3):521-531.
11. Jeffrey JJ, Gross J: Collagenase from rat uterus.: Isolation and partial characterization. Biochemistry 1970, 9(2):268-273.
12. Talhouk RS, Bissell MJ, Werb Z: Expression of extracellular matrix degrading proteinases and their inhibitors during involution of the mammary gland in CD-1 mice. J Cell Biol 1990, 111(1):14a.
13. Talhouk RS, Bissell MJ, Werb Z: Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 1992, 118(5):1271-1282.
14. Wilson MJ, Norris H, Woodson M, Sinha AA: Effect of castration on melloproteinase activities in the lateral, dorsal, and anterior lobes of the prostate. Arch Androl 1995, 35(2):119-125.
15. Powell WC, Dormann FE Jr, Michen JM, Matrisian LM, Nagle RB, Bowden GT: Matrilysin expression in the involuting rat ventral prostate. Prostate 1996, 29(3):159-168.
16. Endo T, Aten RF, Wang F, Behrman HR: Coordinate induction and activation of metalloproteinase and ascorbate depletion in structural luteolysis. Endocrinology 1993, 133(2):690-698.
17. Goto T, Endo T, Henmi H, Kitajima Y, Kiya T, Nishikawa A, Manase K, Sato H, Kudo R: Gonadotripin-releasing hormone agonist has the ability to induce increased matrix metalloproteinase (MMP)-2 and membrane type-1 MMP expression in corpora lutea, and structural luteolysis in rats. J Endocrinol 1999:393-402.
18. Manase K, Endo T, Henmi H, Kitajima Y, Yamazaki K, Nishikawa A, Mitaka T, Sato H, Kudo R: The significance of membrane type 1 metalloproteinase in structural involution of human corpora lutea. Mol Hum Reprod 2002, 8(8):742-749.
19. Harkness RD, Moralee BE: The time course and route of loss of collagen from the rat's uterus during post-partum involution. J Physiol 1956, 132(3):502-508.
20. Liu X, Wu H, Byrne M, Jeffrey J, Krane S, Jaenisch R: A targeted mutation at the known collagenase cleavage site in mouse type 11 collagen impairs tissue remodeling. J Cell Biol 1995, 130(1):227-237.
21. Nishikawa A, Iwasaki M, Akutagawa N, Manase K, Yamashita S, Endo T, Kudo R: Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: Correlation to invasive potential. Gynecol Oncol 2000, 79(2):256-263.
22. Kuwano Y, Olvera J, Wool IG: The primary structure of rat ribosomal protein L38. Biochem Biophys Res 1991, 175(2):551-555.
23. Luborsky JL, Dorflinger LJ, Wright K, Berman HR: Prostaglandin F2αinhibits luteinizing hormone (LH)-induced increase in LH receptor binding to isolated rat luteal cells. Endocrinology 1984, 115:2210-2216.
24. Shimizu K, Furuya T, Takeo Y, Shirama K, Maekawa K: Clearance of materials from breakdown of uterine collagen in mice during postpartum involution. Acta Anat (Basel) 1983, 116(1):10-13.
25. Stygar D, Wang H, Vladic YS, Ekman G, Eriksson H, Sahlin L: Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix. Biol Reprod 2002, 67:889-94.
26. Regulation of matrix metalloproteinases (type IV collagenases) and their inhibitors in the virgin, timed pregnant, and postpartum rat uterus and cervix by prostaglandin E(2)-cyclic adenosine monophosphate. Am J Obstet Gynecol 2002, 187(1):202-8.
27. Roh CR, Oh WJ, Yoon BK, Lee JH: Up-regulation of matrix metalloproteinase-9 in human myometrium during labour: a cytokine-mediated process in uterine smooth muscle cells. Mol Hum Reprod 2000, 6:96-102.
28. Shimada H, Okamura H, Espey LL, Mori T: Increase in plasminogen activator in the involuting uterus of the postpartum rat. J Endocrinol 1985, 104(2):295-298.
29. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993, 4(2):197-250.
30. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994, 370(6484):61-65.
31. Takino T, Sato H, Yamamoto E, Seiki M: Cloning of a human gene potentially encoding a novel matrix metalloproteinase having a C-terminal transmembrane domain. Gene 1955, 155(2):293-298.
32. Kinoshita T, Sato H, Takino T, Itoh M, Akizawa T, Seiki M: Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase. Cancer Res 1996, 56(11):2535-2538.
33. Umenishi F, Umeda M, Miyazaki K: Efficient purification of TIMP-2 from culture medium conditioned by human hepatoma cell line, and its inhibitory effects on mettaloproteinase and in vitro tumor invasion. J Cell Biol 1991, 110(2):189-195.
34. Aimes RT, Quigley JP: Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type 1 collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem 1995, 270(11):5872-5876.
35. Willenbrock F, Murphy G: Structure-function relationships in the tissue inhibitory effects of metalloproteinase. Am J Respir Crit Care Med 1994, 150(6Pt2):S165-S170.
36. Stetler-Stevenson WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinase 2 (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 1989, 264(29):5331-239.
37. Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y: Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinase 2. Cancer Res 1996, 56(2):2707-2710.
38. Sato H, Okada Y, Seiki M: Membrane-type matrix metalloproteinases (MT-MMPs) in cell invation. Thromb Haemost 1997, 78(1):497-500.
39. Kinoshita T, Sato H, Okada A, Ohuchi E, Imai K, Okada Y, Seiki M: TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem 1998, 273(26):16098-16103.